Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Partnerships

<< Previous

Bullboard Posts

Next >>

Comment by scarlet1967on May 14, 2021 4:25pm

118 Views

Post# 33205413

RE:RE:RE:RE:RE:Partnerships

The possible collaboration with other pharmas has been addressed here sines the Stone Age

canadapiet wrote: Wow,

now we are talking here about "a partner".......
Something i mentioned over and over years ago when talking with Mr. T. and recently Mrs. G. !!!

They want to keep it "inside" the company because that will reward the shareholders the most.............!!! Hilarious, isn't it???

Good luck